You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Ajanta Pharma Ltd"

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 22/03/2017
  • |
  • bse

Ajanta Pharma Ltd Amalgamation/ Merger / Demerger

  • 18/03/2017
  • |
  • bse

Ajanta Pharma Ltd Board approves Dividend

  • 18/03/2017
  • |
  • bse

Ajanta Pharma Ltd Outcome of Board Meeting

  • 18/03/2017
  • |
  • bse

Ajanta Pharma Ltd Closure of Trading Window

  • 15/03/2017
  • |
  • bse

Ajanta Pharma Ltd Board Meeting On Saturday 18Th March 2017 Record Date For Determining The Shareholders Entitled T

  • 15/03/2017
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 07/03/2017
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 27/02/2017
  • |
  • bse

Ajanta Pharma Ltd Change in address of Registrar & Share Transfer Agent

  • 27/02/2017
  • |
  • bse

Ajanta Pharma Ltd USFDA inspection for Paithan plant

  • 09/02/2017
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 02/02/2017
  • |
  • bse

Ajanta Pharma Ltd Investor Presentation Q3 FY 2017

  • 24/01/2017
  • |
  • bse

Ajanta Pharma Ltd Announces Q3 results (Standalone & Consolidated) Limited Review Report (Standalone & Consolidated) &

  • 24/01/2017
  • |
  • bse

Ajanta Pharma Ltd No import alert on us by US FDA

  • 24/01/2017
  • |
  • bse

Ajanta Pharma Ltd Clarifies on News item

  • 24/01/2017
  • |
  • bse

Ajanta Pharma Ltd Clarification sought from Ajanta Pharma Ltd

  • 24/01/2017
  • |
  • bse

Ajanta Pharma Ltd Q3 results on Jan 24 2017

  • 13/01/2017
  • |
  • bse

Ajanta Pharma Ltd Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended D

  • 10/01/2017
  • |
  • bse

Ajanta Pharma Ltd Ajanta Pharma Announces US FDA Approval for Duloxetine Hydrochloride Delayed Release Capsules

  • 09/01/2017
  • |
  • bse

Ajanta Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 23/12/2016
  • |
  • bse